Line 2,024: |
Line 2,024: |
| |Kikuchi-Fujimoto disease||Disease|| || || || || ||Sumi Kitahara (SK) | | |Kikuchi-Fujimoto disease||Disease|| || || || || ||Sumi Kitahara (SK) |
| | || | | | || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |Autoimmune lymphoproliferative syndrome||Disease|| || || || || ||SK|| || | | |Autoimmune lymphoproliferative syndrome||Disease|| || || || || ||SK|| || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |Indolent T-lymphoblastic proliferation||Disease|| || || || || ||SK|| || | | |Indolent T-lymphoblastic proliferation||Disease|| || || || || ||SK|| || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |T-lymphoblastic leukaemia / lymphoma, NOS||Disease|| || || || || ||HD|| || | | |T-lymphoblastic leukaemia / lymphoma, NOS||Disease|| || || || || ||HD|| || |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |Early T-precursor lymphoblastic leukaemia / lymphoma | | |Early T-precursor lymphoblastic leukaemia / lymphoma |
Line 2,061: |
Line 2,061: |
| | | | | |
| | | | | |
− | | | + | |Early T-Cell Precursor Lymphoblastic Leukemia |
| |Fei Yang, MD, FACMG, Kaiser Permanente Northwest | | |Fei Yang, MD, FACMG, Kaiser Permanente Northwest |
− | | | + | |Pending |
| | | | | |
| | | | | |
Line 2,077: |
Line 2,077: |
| | | | | |
| | | | | |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
− | | | + | |NEW (No Prior) |
| |- | | |- |
| |T-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| || | | |T-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| || |
− | | | + | |T-cell Large Granular Lymphocytic Leukemia |
− | |*Michelle Don, MD, MS | + | |Michelle Don, MD, MS |
− | | | + | |Pending |
| | | | | |
| | | | | |
| |- | | |- |
| |NK-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| || | | |NK-large granular lymphocytic leukaemia||Disease|| || || || || ||SK|| || |
− | | | + | |Chronic Lymphoproliferative Disorder of NK Cells |
| |Michelle Don, MD | | |Michelle Don, MD |
− | | | + | |Pending |
| | | | | |
| | | | | |
| |- | | |- |
| |Adult T-cell leukaemia/lymphoma||Disease|| || || || || ||SK|| || | | |Adult T-cell leukaemia/lymphoma||Disease|| || || || || ||SK|| || |
− | | | + | |Adult T-cell Leukemia/Lymphoma |
| |Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center | | |Prasad R. Kopparapu, PhD and Ferrin C. Wheeler, PhD, FACMG Vanderbilt University Medical Center |
− | | | + | |?Pending |
| | | | | |
| | | | | |
| |- | | |- |
| |Sezary syndrome||Disease|| || || || || ||SK|| || | | |Sezary syndrome||Disease|| || || || || ||SK|| || |
− | | | + | |Sézary Syndrome |
| |Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina | | |Madison E. Hannay, DO, Medical University of South Carolina Tingting Barrett, MD, Medical University of South Carolina Daynna J. Wolff, PhD, Medical University of South Carolina |
− | | | + | |Pending |
| | | | | |
| | | | | |
| |- | | |- |
| |Aggressive NK-cell leukaemia||Disease|| || || || || ||SK|| || | | |Aggressive NK-cell leukaemia||Disease|| || || || || ||SK|| || |
− | | | + | |Aggressive NK-cell Leukemia |
| |Shanelle De Lancy, MD, Shashirekha Shetty, PhD | | |Shanelle De Lancy, MD, Shashirekha Shetty, PhD |
− | | | + | |?Pending |
| | | | | |
| | | | | |